CVR: 34083738
Not available
Net result: DKK -59,597,000
Novo Holdings A/S, Canaan XII L.P.
2 more
CVR · view ownership and management
Owner registered: Novo Holdings A/S
CVR · 22/12/2025
View the full event history
ACESION PHARMA ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2011. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Anders Gaarsdal Holst. The company's owners include Novo Holdings A/S, Canaan XII L.P. and Alpha Wave Ventures II, LP. The company has 14 employees (2018). In 2025, the company reported a net result of DKK -59,597,000 compared with DKK -43,033,000 the year before. Equity in the 2025 report amounted to DKK 276,067,000.
Selskabets formål er at udvikle lægemidler til medicinsk behandling af atrieflimmer.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | - | -59.6 mio. | 287.3 mio. | 276.1 mio. | - | |
| 202401/01/2024 – 31/12/2024 | - | -43 mio. | 116.1 mio. | 89.6 mio. | - | |
| 202301/01/2023 – 31/12/2023 | - | -42.8 mio. | 165.9 mio. | 130.8 mio. | - | |
| 202201/01/2022 – 31/12/2022 | - | -46.8 mio. | 53.2 mio. | 23 mio. | - | |
| 202101/01/2021 – 31/12/2021 | 0 | -25.2 mio. | 34 mio. | 10.3 mio. | - | |
| 202001/01/2020 – 31/12/2020 | 0 | -31.4 mio. | 64.5 mio. | -20 mio. | - | |
| 201901/01/2019 – 31/12/2019 | - | -41.2 mio. | 31.5 mio. | 524 t. | 7 | |
| 201801/01/2018 – 31/12/2018 | - | -25.1 mio. | 29.4 mio. | -6.5 mio. | 10 | |
| 201701/01/2017 – 31/12/2017 | - | -24 mio. | 22.8 mio. | -9.9 mio. | 12 | |
| 201601/01/2016 – 31/12/2016 | - | -18.3 mio. | 39.8 mio. | 14.1 mio. | - | |
| 201501/01/2015 – 31/12/2015 | - | -9.8 mio. | 17.3 mio. | 1.5 mio. | - | |
| 201401/01/2014 – 31/12/2014 | - | -6.5 mio. | 18.9 mio. | 3.8 mio. | - | |
| 201301/01/2013 – 31/12/2013 | - | -6.5 mio. | 9.1 mio. | -556 t. | - | |
| 201215/12/2011 – 31/12/2012 | - | -2.1 mio. | 2.6 mio. | 2 mio. | - |
Screen owners and management against the Danish FSA's official PEP lists
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationACESION PHARMA ApS was founded on 15 December 2011.
ACESION PHARMA ApS is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (industry code 721000).
ACESION PHARMA ApS had 14 employees in 2018 according to the Danish CVR register.
The owners of ACESION PHARMA ApS include Novo Holdings A/S, Canaan XII L.P. and Alpha Wave Ventures II, LP.
The management of ACESION PHARMA ApS consists of Anders Gaarsdal Holst.
ACESION PHARMA ApS is located at Nordre Fasanvej 215, 2000 Frederiksberg.
Claim this page to add your logo and social links. Free to get started.
ACESION PHARMA ApS has published its annual report for 2025. The net result was DKK -59,597,000.
As of December 22, 2025, Novo Holdings A/S is registered as an owner of ACESION PHARMA ApS with an ownership share of 33%.
As of December 22, 2025, is registered as an owner of ACESION PHARMA ApS with an ownership share of 20%.
As of December 22, 2025, is registered as an owner of ACESION PHARMA ApS with an ownership share of 15%.
As of December 22, 2025, is registered as an owner of ACESION PHARMA ApS with an ownership share of 5%.
ACESION PHARMA ApS has published its annual report for 2024. The net result was DKK -43,033,000.
ACESION PHARMA ApS has published its annual report for 2023. The net result was DKK -42,849,000.
As of February 28, 2024, Benjamin Bruno Thorner has joined the board of directors of ACESION PHARMA ApS.
As of September 15, 2023, Timothy Michael Shannon has joined the board of directors of ACESION PHARMA ApS.
As of September 15, 2023, Nik Economopoulos has joined the board of directors of ACESION PHARMA ApS.
As of September 15, 2023, Morten Grunnet has left the board of directors of ACESION PHARMA ApS.
As of September 15, 2023, Morten Døssing has left the board of directors of ACESION PHARMA ApS.
As of September 15, 2023, Karen Juo-Lai Chu has left the board of directors of ACESION PHARMA ApS.
ACESION PHARMA ApS has published its annual report for 2022. The net result was DKK -46,780,000.
ACESION PHARMA ApS has published its annual report for 2021. Revenue came to DKK 0, and the net result was DKK -25,157,000.
As of June 1, 2022, Anders Gaarsdal Holst is registered as adm. dir. of ACESION PHARMA ApS.
As of June 1, 2022, Torgeir Vaage has stepped down as director of ACESION PHARMA ApS.
As of January 6, 2022, Ann Mills-Duggan has left the board of directors of ACESION PHARMA ApS.
ACESION PHARMA ApS has published its annual report for 2020. Revenue came to DKK 0, and the net result was DKK -31,428,000.
As of October 19, 2020, EY Godkendt Revisionspartnerselskab has been appointed auditor of ACESION PHARMA ApS.
As of October 19, 2020, PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab has stepped down as auditor of ACESION PHARMA ApS.
As of June 30, 2020, Frans Gustaf Wuite has stepped down as adm. dir. of ACESION PHARMA ApS.
ACESION PHARMA ApS has published its annual report for 2019. Gross profit came to DKK -35,793,780, and the net result was DKK -41,223,161.
As of May 28, 2020, Jørgen Søberg Petersen has joined the board of directors of ACESION PHARMA ApS.
As of May 28, 2020, Ingelise Saunders has left the board of directors of ACESION PHARMA ApS.
As of May 28, 2020, Paul David Goldenheim has left the board of directors of ACESION PHARMA ApS.
As of September 9, 2019, Morten Døssing has joined the board of directors of ACESION PHARMA ApS.
As of September 9, 2019, Karen Juo-Lai Chu has joined the board of directors of ACESION PHARMA ApS.
As of September 9, 2019, Stephan Christgau has left the board of directors of ACESION PHARMA ApS.
As of September 9, 2019, Duan Xiang has left the board of directors of ACESION PHARMA ApS.
ACESION PHARMA ApS has published its annual report for 2018. Gross profit came to DKK -18,647,333, and the net result was DKK -25,088,392.
As of January 23, 2019, Duan Xiang has joined the board of directors of ACESION PHARMA ApS.
As of December 1, 2018, Torgeir Vaage is registered as director of ACESION PHARMA ApS.
As of December 1, 2018, Jakob Dynnes Hansen has stepped down as director of ACESION PHARMA ApS.
As of October 22, 2018, Ann Mills-Duggan has joined the board of directors of ACESION PHARMA ApS.
As of August 31, 2018, Georgios Trichas has left the board of directors of ACESION PHARMA ApS.
ACESION PHARMA ApS has published its annual report for 2017. Gross profit came to DKK -17,450,508, and the net result was DKK -23,972,490.
As of October 25, 2017, Georgios Trichas has joined the board of directors of ACESION PHARMA ApS.
As of October 25, 2017, Lars Gredsted has left the board of directors of ACESION PHARMA ApS.
ACESION PHARMA ApS has published its annual report for 2016. Gross profit came to DKK -14,393,708, and the net result was DKK -18,262,257.
As of March 17, 2017, Jakob Dynnes Hansen is registered as director of ACESION PHARMA ApS.
As of January 13, 2017, Lars Gredsted has joined the board of directors of ACESION PHARMA ApS.
ACESION PHARMA ApS has published its annual report for 2015. Gross profit came to DKK -8,496,428, and the net result was DKK -9,804,270.
As of May 2, 2016, Morten Grunnet has stepped down as director of ACESION PHARMA ApS.
As of April 1, 2016, Frans Gustaf Wuite is registered as adm. dir. of ACESION PHARMA ApS.
As of April 1, 2016, Ulrik Svane Sørensen has stepped down as adm. dir. of ACESION PHARMA ApS.
As of February 1, 2016, Paul David Goldenheim has joined the board of directors of ACESION PHARMA ApS.
As of February 1, 2016, Carsten Schou has left the board of directors of ACESION PHARMA ApS.
As of August 15, 2015, Stephan Christgau has joined the board of directors of ACESION PHARMA ApS.
As of August 15, 2015, Bobby G Soni has left the board of directors of ACESION PHARMA ApS.
ACESION PHARMA ApS has published its annual report for 2014. Gross profit came to DKK -4,722,342, and the net result was DKK -6,455,117.
As of August 1, 2014, Bobby G Soni has joined the board of directors of ACESION PHARMA ApS.
As of August 1, 2014, Ingelise Saunders has joined the board of directors of ACESION PHARMA ApS.
As of August 1, 2014, Carsten Schou has joined the board of directors of ACESION PHARMA ApS.
As of August 1, 2014, Frank Knudsen has left the board of directors of ACESION PHARMA ApS.
ACESION PHARMA ApS has published its annual report for 2013. Gross profit came to DKK -4,833,419, and the net result was DKK -6,507,161.
ACESION PHARMA ApS has published its annual report for 2012. Gross profit came to DKK -1,313,935, and the net result was DKK -2,068,513.
As of December 15, 2011, PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab has been appointed auditor of ACESION PHARMA ApS.
As of December 15, 2011, Frank Knudsen has joined the board of directors of ACESION PHARMA ApS.
As of December 15, 2011, Morten Grunnet has joined the board of directors of ACESION PHARMA ApS.
As of December 15, 2011, Ulrik Svane Sørensen is registered as adm. dir. of ACESION PHARMA ApS.
As of December 15, 2011, Morten Grunnet is registered as director of ACESION PHARMA ApS.
ACESION PHARMA ApS was founded on December 15, 2011.
Companies in the same industry and area
CVR 40766383
CVR 42597333
CVR 46613139
CVR 44504332
CVR 43917897
